Francois MarteletChief Executive Officer
Francois Martelet is an experienced Pharma executive with a proven track record of shaping companies and turning around underperforming units. He has held three CEO positions in the last 12 years. He has spent most of his career in the oncology field, as CEO of Avax and Topotarget, as well as in executive roles at senior level at Roche, Eli Lilly, Novartis and MSD. He has been based in six countries in Europe (including Sweden) and in the US. Francois Martelet is a French Medical Doctor, with a Masters Degree in Business. He speaks four languages, among them Swedish.
Anette SjödinChief Business Officer and deputy CEO
Share holdings: 3,000 shares.
Anette Sjödin possesses more than 25 years of experience in the Life Science sector. She is a biochemist with many years of global experience including senior positions in marketing, project management and business development. Her most recent position was in business development at Nestlé Skin Health where she has worked internationally with in- and out licensing and was responsible for strategic alliances.
Mikael AspChief Technical Officer
Share holdings: 15,180 shares.
Mikael has a Master of Science in Chemical Engineering and has 30 years of experience from several companies within the international pharmaceutical industry in research and development, production, quality assurance and as Qualified Person (QP).
Nina HeldringActing Chief Medical Officer
Share holdings: 12,084 shares.
Nina Heldring, PhD, has 20 years of experience in preclinical and clinical medical research from well-known academic institutes such as Cornell University in the US and Karolinska Institutet but also the pharmaceutical industry. She started as Head of Clinical Development at Oasmia in 2016 and has led the work on pharmacovigilance and clinical trials. Nina took up her new position as Acting Chief Medical Officer in July 2019.
Reinhard KoenigGeneral Manager, US & Canada (acting)
Share holdings: –
Reinhard Koenig has more than 30 years of pharma and biotechnology experience. He has extensive experience of leading positions within global pharmaceutical companies. Previous companies include Genentech, Boehringer Mannheim and Piramal Critical Care.
Michael af WinklerfeltChief Financial Officer
Share holdings: 84,960 shares.
Michael af Winklerfelt has more than 15 years of experience from senior finance roles in leading international companies. He worked for ten years in China for the Atlas Copco Group and most recently spent three years in the United States in the medical device field. He has an MBA, an M.Sc. in Economics and Business and an unfinished B.A. in Chinese.
Neil YmanGM Europe & Russia
Share holdings: 76,984 shares.
Neil Yman has over 17 years of pharma and oncology experience in positions with Pierre Fabre, Novartis, GSK and Roche. He has extensive experience of leading positions within global pharmaceutical companies.